Bimzelx

Pharma

UCB collects 3 new FDA approvals for blockbuster hopeful Bimzelx

Along with psoriasis, the biologic is now approved to treat psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis.

Zoey Becker Sep 23, 2024 12:12pm

After delays, UCB's psoriasis med Bimzelx finally scores FDA nod

Oct 18, 2023 12:04pm